Zynex Share Price (NASDAQ: ZYXI)

$1.67

▲

-0.01

(-0.6%)

Live

Last updated on August 28, 2025 at 11:41 pm IST

$₹

Check the interactive Zynex Stock chart to analyse performance

Zynex Inc Key Stats

Check Zynex key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.68
Open	$1.69
Market Capitalization	$50.9M
Today's Volume	$67.2K
Revenue TTM	$144.8M
EBITDA	$-15.3M
Earnings Per Share (EPS)	$-0.93
Profit Margin	-19.79%
Quarterly Earnings Growth YOY	-0.3%
Return On Equity TTM	-168.22%

Stock Returns calculator for Zynex Stock including INR - Dollar returns

The Zynex stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zynex investment value today

Current value as on today

₹25,419

Returns

₹74,581

(-74.58%)

Returns from Zynex Stock

₹78,941 (-78.94%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Zynex Stock

227%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Zynex Stock from India on INDmoney has increased by 227% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Zynex Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
4.16%
Vanguard Group Inc
3.13%
Janney Montgomery Scott LLC
1.45%
Geode Capital Management, LLC
1.28%
State Street Corp
1.19%
Two Sigma Advisers, LLC
0.99%

Analyst Recommendation on Zynex Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Zynex(by analysts ranked 0 to 5 stars)

Zynex Share Price Target

What analysts predicted

Upside of 70.66%

Target:

$2.85

Current:

$1.67

Zynex share price target is $2.85, a slight Upside of 70.66% compared to current price of $1.67 as per analysts' prediction.

Zynex Stock Insights

Price Movement
In the last 7 days, ZYXI stock has moved up by 9.8%
Decreasing Revenue
Revenue is down for the last 4 quarters, 49.96M → 22.29M (in $), with an average decrease of 22.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 2.38M → -20.03M (in $), with an average decrease of 603.0% per quarter
ZYXI vs CAH (1 yr)
In the last 1 year, Cardinal Health, Inc. has given 34.4% return, outperforming this stock by 113.2%
ZYXI vs CAH (3 yr)
In the last 3 years, Cardinal Health, Inc. has given 120.8% return, outperforming this stock by 202.6%
Price to Sales
ForZYXI every $1 of sales, investors are willing to pay $0.4, whereas for Cardinal Health, Inc., the investors are paying $0.2 for every $1 of sales.

Zynex Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$45.5M	↑ 42.47%
Net Income	$9.5M	↓ 0.63%
Net Profit Margin	20.87%	↓ 9.06%

	FY20	Y/Y Change
Revenue	$80.1M	↑ 76.2%
Net Income	$9.1M	↓ 4.4%
Net Profit Margin	11.33%	↓ 9.54%

	FY21	Y/Y Change
Revenue	$130.3M	↑ 62.63%
Net Income	$17.1M	↑ 88.48%
Net Profit Margin	13.13%	↑ 1.8%

	FY22	Y/Y Change
Revenue	$158.2M	↑ 21.39%
Net Income	$17.0M	↓ 0.32%
Net Profit Margin	10.78%	↓ 2.35%

	FY23	Y/Y Change
Revenue	$184.3M	↑ 16.54%
Net Income	$9.7M	↓ 42.91%
Net Profit Margin	5.28%	↓ 5.5%

	FY24	Y/Y Change
Revenue	$192.4M	↑ 4.36%
Net Income	$3.0M	↓ 69.24%
Net Profit Margin	1.56%	↓ 3.72%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$46.5M	↓ 1.59%
Net Income	$10.0K	↓ 99.18%
Net Profit Margin	0.02%	↓ 2.55%

	Q2 FY24	Q/Q Change
Revenue	$49.9M	↑ 7.2%
Net Income	$1.2M	↑ 12070.0%
Net Profit Margin	2.44%	↑ 2.42%

	Q3 FY24	Q/Q Change
Revenue	$50.0M	↑ 0.17%
Net Income	$2.4M	↑ 95.73%
Net Profit Margin	4.77%	↑ 2.33%

	Q4 FY24	Q/Q Change
Revenue	$46.0M	↓ 7.99%
Net Income	$-615.0K	↓ 125.82%
Net Profit Margin	-1.34%	↓ 6.11%

	Q1 FY25	Q/Q Change
Revenue	$26.6M	↓ 42.19%
Net Income	$-10.4M	↑ 1590.41%
Net Profit Margin	-39.12%	↓ 37.78%

	Q2 FY25	Q/Q Change
Revenue	$22.3M	↓ 16.13%
Net Income	$-20.0M	↑ 92.7%
Net Profit Margin	-89.87%	↓ 50.75%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$36.7M	↑ 41.65%

	FY20	Y/Y Change
Profit	$62.7M	↑ 71.05%

	FY21	Y/Y Change
Profit	$103.0M	↑ 64.23%

	FY22	Y/Y Change
Profit	$126.2M	↑ 22.51%

	FY23	Y/Y Change
Profit	$146.0M	↑ 15.69%

	FY24	Y/Y Change
Profit	$152.9M	↑ 4.77%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$37.2M	↑ 0.59%

	Q2 FY24	Q/Q Change
Profit	$39.9M	↑ 7.2%

	Q3 FY24	Q/Q Change
Profit	$39.8M	↓ 0.31%

	Q4 FY24	Q/Q Change
Profit	$36.0M	↓ 9.55%

	Q1 FY25	Q/Q Change
Profit	$18.2M	↓ 49.41%

	Q2 FY25	Q/Q Change
Profit	$15.2M	↓ 16.33%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$6.3M	↓ 33.0%
Investing Cash Flow	$-160.0K	↓ 85.21%
Financing Cash Flow	$-2.2M	↓ 40.71%

	FY20	Y/Y Change
Operating Cash Flow	$818.0K	↓ 87.02%
Investing Cash Flow	$-985.0K	↑ 515.63%
Financing Cash Flow	$25.3M	↓ 1234.02%

	FY21	Y/Y Change
Operating Cash Flow	$6.9M	↑ 749.51%
Investing Cash Flow	$-16.6M	↑ 1585.89%
Financing Cash Flow	$13.1M	↓ 48.24%

	FY22	Y/Y Change
Operating Cash Flow	$13.7M	↑ 97.81%
Investing Cash Flow	$-418.0K	↓ 97.48%
Financing Cash Flow	$-35.8M	↓ 373.34%

	FY23	Y/Y Change
Operating Cash Flow	$17.8M	↑ 29.17%
Investing Cash Flow	$-966.0K	↑ 131.1%
Financing Cash Flow	$7.6M	↓ 121.36%

	FY24	Y/Y Change
Operating Cash Flow	$12.7M	↓ 28.36%
Investing Cash Flow	$-578.0K	↓ 40.17%
Financing Cash Flow	$-17.1M	↓ 323.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$2.1M	↓ 66.99%
Investing Cash Flow	$-153.0K	↓ 101.62%
Financing Cash Flow	$-13.6M	↑ 0.61%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.1M	↓ 45.16%
Investing Cash Flow	$-137.0K	↓ 10.46%
Financing Cash Flow	$-3.0M	↓ 78.27%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$7.1M	↑ 523.81%
Investing Cash Flow	$-72.0K	↓ 47.45%
Financing Cash Flow	$-268.0K	↓ 90.95%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$2.4M	↓ 65.44%
Investing Cash Flow	$-216.0K	↑ 200.0%
Financing Cash Flow	$-228.0K	↓ 14.93%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-10.5M	↓ 529.57%
Investing Cash Flow	$-168.0K	↓ 22.22%
Financing Cash Flow	$-5.1M	↑ 2140.35%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-6.2M	↓ 40.97%
Investing Cash Flow	$-29.0K	↓ 82.74%
Financing Cash Flow	$-80.0K	↓ 98.43%

Zynex Technicals Summary

Sell

Neutral

Buy

Zynex is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Zynex Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zynex Inc	-32.26%	-77.42%	-78.81%	-81.46%	-87.51%
Cardinal Health, Inc.	-5.18%	17.08%	34.4%	114.15%	194.01%
Mckesson Corporation	-4.02%	10.09%	22.78%	88.28%	345.46%
Henry Schein, Inc.	-1.53%	-4.35%	-2.13%	-6.92%	3.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zynex Inc	18.44	NA	0.0	-1.36	-1.68	-0.12	NA	0.04
Cardinal Health, Inc.	22.87	22.87	1.52	9.43	0.0	0.03	0.01	-11.64
Mckesson Corporation	27.24	27.24	1.09	32.78	0.0	0.04	0.0	-15.74
Henry Schein, Inc.	22.21	22.21	1.72	4.82	0.08	0.05	NA	28.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zynex Inc	Buy	$50.9M	-87.51%	18.44	-19.79%
Cardinal Health, Inc.	Hold	$35.2B	194.01%	22.87	0.7%
Mckesson Corporation	Buy	$84.6B	345.46%	27.24	0.84%
Henry Schein, Inc.	Hold	$8.4B	3.82%	22.21	3.05%

About Zynex Inc

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Organization	Zynex
Employees	1000
CEO	Mr. Thomas Sandgaard
Industry	Medical Specialties

Key Management of Zynex Inc

Name	Title
Mr. Thomas Sandgaard	Founder, President & Chairman
Ms. Anna Lucsok	Chief Operating Officer
Mr. Vikram Bajaj	Chief Financial Officer
Mr. John T. Bibb	Chief Legal Officer
Mr. Ajay Gopal	Executive Vice President of Sales
Mr. Neil Friery	COO of Zynex Monitoring Solutions, Inc.
Mr. Donald Gregg	President of Zynex Monitoring Solutions

Important FAQs about investing in ZYXI Stock from India :

What is Zynex share price today?

Zynex share price today is $1.67 as on August 28, 2025 at 11:41 pm IST. Zynex share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Zynex share?

Zynex share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Zynex stock price today i.e. August 28, 2025 at 11:41 pm IST is trending at $1.67, lower by 82.27% versus the 52 week high.

How to invest in Zynex Stock (ZYXI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zynex on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zynex Shares that will get you 0.8982 shares as per Zynex share price of $1.67 per share as on August 28, 2025 at 11:41 pm IST.

What is the minimum amount required to buy Zynex Stock (ZYXI) from India?

Indian investors can start investing in Zynex (ZYXI) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Zynex stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Zynex share’s latest price of $1.67 as on August 28, 2025 at 11:41 pm IST, you will get 5.9880 shares of Zynex. Learn more about fractional shares .

What are the returns that Zynex has given to Indian investors in the last 5 years?

Zynex stock has given -87.51% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?